These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 20532119)

  • 1. Ramelteon: a novel hypnotic indicated for the treatment of insomnia.
    Zammit GK
    Psychiatry (Edgmont); 2007 Sep; 4(9):36-42. PubMed ID: 20532119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacotherapy of insomnia with ramelteon: safety, efficacy and clinical applications.
    Pandi-Perumal SR; Spence DW; Verster JC; Srinivasan V; Brown GM; Cardinali DP; Hardeland R
    J Cent Nerv Syst Dis; 2011; 3():51-65. PubMed ID: 23861638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ramelteon.
    McGechan A; Wellington K
    CNS Drugs; 2005; 19(12):1057-65; discussion 1066-7. PubMed ID: 16332146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ramelteon for the treatment of insomnia.
    Borja NL; Daniel KL
    Clin Ther; 2006 Oct; 28(10):1540-55. PubMed ID: 17157111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical appraisal of ramelteon in the treatment of insomnia.
    Mets MA; van Deventer KR; Olivier B; Verster JC
    Nat Sci Sleep; 2010; 2():257-66. PubMed ID: 23616713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology of ramelteon, a selective MT1/MT2 receptor agonist: a novel therapeutic drug for sleep disorders.
    Miyamoto M
    CNS Neurosci Ther; 2009; 15(1):32-51. PubMed ID: 19228178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A novel therapeutic drug: ramelteon].
    Miyamoto M
    Nihon Rinsho; 2009 Aug; 67(8):1595-600. PubMed ID: 19768947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melatonin agonists in primary insomnia and depression-associated insomnia: are they superior to sedative-hypnotics?
    Srinivasan V; Brzezinski A; Pandi-Perumal SR; Spence DW; Cardinali DP; Brown GM
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):913-23. PubMed ID: 21453740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effects.
    Johnson MW; Suess PE; Griffiths RR
    Arch Gen Psychiatry; 2006 Oct; 63(10):1149-57. PubMed ID: 17015817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic and pharmacodynamic evaluation of ramelteon : an insomnia therapy.
    Spadoni G; Bedini A; Lucarini S; Mor M; Rivara S
    Expert Opin Drug Metab Toxicol; 2015 Jul; 11(7):1145-56. PubMed ID: 25956235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ramelteon: a novel approach in the treatment of insomnia.
    Reynoldson JN; Elliott E; Nelson LA
    Ann Pharmacother; 2008 Sep; 42(9):1262-71. PubMed ID: 18648020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melatonergic drugs in clinical practice.
    Hardeland R; Poeggeler B; Srinivasan V; Trakht I; Pandi-Perumal SR; Cardinali DP
    Arzneimittelforschung; 2008; 58(1):1-10. PubMed ID: 18368944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacotherapies for sleep disturbances in dementia.
    McCleery J; Cohen DA; Sharpley AL
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD009178. PubMed ID: 27851868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ramelteon: a review of its therapeutic potential in sleep disorders.
    Pandi-Perumal SR; Srinivasan V; Spence DW; Moscovitch A; Hardeland R; Brown GM; Cardinali DP
    Adv Ther; 2009 Jun; 26(6):613-26. PubMed ID: 19568703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ramelteon 8 mg/d versus placebo in patients with chronic insomnia: post hoc analysis of a 5-week trial using 50% or greater reduction in latency to persistent sleep as a measure of treatment effect.
    Mini L; Wang-Weigand S; Zhang J
    Clin Ther; 2008 Jul; 30(7):1316-23. PubMed ID: 18691991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ramelteon: a review of its use in insomnia.
    Simpson D; Curran MP
    Drugs; 2008; 68(13):1901-19. PubMed ID: 18729542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacotherapies for sleep disturbances in Alzheimer's disease.
    McCleery J; Cohen DA; Sharpley AL
    Cochrane Database Syst Rev; 2014 Mar; (3):CD009178. PubMed ID: 24659320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of 6-month nightly ramelteon administration in adults with chronic primary insomnia.
    Mayer G; Wang-Weigand S; Roth-Schechter B; Lehmann R; Staner C; Partinen M
    Sleep; 2009 Mar; 32(3):351-60. PubMed ID: 19294955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin and melatonergic drugs in sleep disorders.
    Kim HK; Yang KI
    Transl Clin Pharmacol; 2022 Dec; 30(4):163-171. PubMed ID: 36632077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-reported efficacy and tolerability of ramelteon 8 mg in older adults experiencing severe sleep-onset difficulty.
    Mini LJ; Wang-Weigand S; Zhang J
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):177-84. PubMed ID: 17996657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.